Ignite Creation Date:
2024-05-06 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05828147
Status:
RECRUITING
Last Update Posted:
2024-02-07
First Post:
2023-03-28
Brief Title:
Anti-CD20 Antibodies for Treatment of SLE-PAH
Sponsor:
Chinese SLE Treatment And Research Group
Organization:
Chinese SLE Treatment And Research Group
Organization Data
Organization:
Chinese SLE Treatment And Research Group
Class:
OTHER
Study ID:
CSTAR-K2761
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chinese SLE Treatment And Research Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None